Effect of VEGF on Tail Artery Interpositional LOOP (TAIL) Flap: A Rodent Model for Flap Prefabrication

ABSTRACT

The authors introduce an experimental model of flap prefabrication, the tail artery interpositional loop (TAIL) flap. In this model, an arterial segment from a rat tail is used to create an arteriovenous (A-V) fistula. This fistula is positioned beneath the abdominal skin flap to vascularize the overlying tissue, and a barrier of Silastic sheeting is placed below the fistula to prevent vascular ingrowth from the underlying bed. The efficacy of this new model was tested by investigating the effect of a single topical application of recombinant human VEGF₁₆₅. Treatment and control groups each contained 20 animals. In the control group, mean survival skin areas at 1, 2, 3, and 4 weeks were 12.5 percent, 27 percent, 35 percent, and 50 percent, respectively. In the VEGF₁₆₅-treated group, survival rates were 14.8 percent, 37 percent, 48 percent, and 74.3 percent, respectively. Statistically significant differences were noted between the two groups at the 2-week (p = 0.047), 3-week (p = 0.048), and 4-week (p = 0.023) time intervals. The authors conclude that the TAIL flap is a novel and useful animal model to study flap prefabrication.

KEYWORDS

Flap prefabrication - rat model - tail artery - interpositional loop flap - VEGF

REFERENCES

• 1 Erol O O. The transformation of a free skin graft into a vascularized pedicled flap.  Plast Reconstr Surg. 1976;  58 470-477
• 2 Valauri F A, Hirase Y, Buncke H J. Prefabricated neovascularized free muscle flaps: pedicle variations.  J Reconstr Microsurg. 1988;  4 203-207
• 3 Takato T, Zuker R M, Turley C B. Prefabrication of skin flaps using vein grafts: an experimental study in rabbits.  Br J Plast Surg. 1991;  44 593-598
• 4 Zhou Z Y, Nichter L S, West B R, Navarrette P M. Evaluation of a temporary arteriovenous shunt to establish neovascularization in a musculocutaneous flap: an experimental study.  Microsurgery. 1994;  15 63-69
• 5 Li Q F, Reis E D, Zhang W X, Silver L, Fallon J T, Weinberg H. Accelerated flap prefabrication with vascular endothelial growth factor.  J Reconstr Microsurg. 2000;  16 45-49
• 6 Wilson Y T, Kumta S, Hickey M J, Hurley J V, Morrison W A. Use of free interpositional vein grafts as pedicles for prefabrication of skin flaps.  Microsurgery. 1994;  15 717-721
• 7 Nakayama Y, Soeda S, Kasai Y. Flaps nourished by arterial inflow through the venous system: an experimental investigation.  Plast Reconstr Surg. 1981;  67 328-334
• 8 Council N R. Guide for the Care and Use of Laboratory Animals. Washington, D.C.; National Academy Press 1996
• 9 Wang F, Zhao M, Huang B et al.. [Subcutaneous injection of plasmid VEGF gene: a method of gene therapy to enhance the viability of random skin flap].  Zhonghua Zheng Xing Wai Ke Za Zhi. 2002;  18 157-159
• 10 Tucci M G, Scalise A, Lucarini G et al.. rhVEGF and experimental rat skin flaps: systemic or local administration and morphological characteristics.  Int J Artif Organs. 2001;  24 743-751
• 11 Kryger Z, Dogan T, Zhang F et al.. Effects of VEGF administration following ischemia in survival of the gracilis muscle flap in the rat.  Ann Plast Surg. 1999;  43 172-178
• 12 Gurunluoglu R, Ozer K, Skugor B, Lubiatowski P, Carnevale K, Siemionow M. Effect of transfection time on the survival of epigastric skin flaps pretreated with adenovirus encoding the VEGF gene.  Ann Plast Surg. 2002;  49 161-169
• 13 O'Toole G, MacKenzie D, Lindeman R et al.. Vascular endothelial growth factor gene therapy in ischaemic rat skin flaps.  Br J Plast Surg. 2002;  55 55-58
• 14 Taub P J, Marmur J D, Zhang W X et al.. Locally administered vascular endothelial growth factor cDNA increases survival of ischemic experimental skin flaps.  Plast Reconstr Surg. 1998;  102 2033-2039
• 15 Nakayama Y, Soeda S, Kasai Y. The importance of arterial inflow in the distal side of a flap: an experimental investigation.  Plast Reconstr Surg. 1982;  69 61-67
• 16 Fukui A, Inada Y, Maeda M, Mizumoto S, Yajima H, Tamai S. Venous flap-its classification and clinical applications.  Microsurgery. 1994;  15 571-578
• 17 Seify H, Bilkay U, Jones G. Improvement of TRAM flap viability using human VEGF-induced angiogenesis: a comparative study of delay techniques.  Plast Reconstr Surg. 2003;  112 1032-1039
• 18 Zhang F, Oswald T, Lin S et al.. Vascular endothelial growth factor (VEGF) expression and the effect of exogenous VEGF on survival of a random flap in the rat.  Br J Plast Surg. 2003;  56 653-659
• 19 Fukui A, Tamai S, Maeda M, Inada Y, Mii Y, Mine T. The pedicled venous flap. An experimental study.  Br J Plast Surg. 1993;  46 116-121
• 20 Matsushita K, Firrell J C, Ogden L, Tsai T M. Blood flow and tissue survival in the rabbit venous flap.  Plast Reconstr Surg. 1993;  91 127-135 discussion 136-137
• 21 Yuen Q M, Leung P C. Some factors affecting the survival of venous flaps: an experimental study.  Microsurgery. 1991;  12 60-64
• 22 Hanawa T, Ikeda S, Funatsu T et al.. [An experimental study on surgical treatment of tracheomalacia-methods for making models of tracheomalacia and development of a new operative method].  Nippon Geka Gakkai Zasshi. 1989;  90 1072-1080
• 23 Semenza G L. Angiogenesis in ischemic and neoplastic disorders.  Annu Rev Med. 2003;  54 17-28
• 24 Sakiyama S E, Schense J C, Hubbell J A. Incorporation of heparin-binding peptides into fibrin gels enhances neurite extension: an example of designer matrices in tissue engineering.  Faseb J. 1999;  13 2214-2224
• 25 Sakiyama-Elbert S E, Hubbell J A. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix.  J Control Release. 2000;  69 149-158
• 26 Sakiyama-Elbert S E, Hubbell J A. Development of fibrin derivatives for controlled release of heparin-binding growth factors.  J Control Release. 2000;  65 389-402